Analysis
Union Square Ventures raised $900 million across two new funds and cut its active general partnership to four people, Bloomberg reported on October 8. The early-stage vehicle is $500 million, up from $275 million in 2024; the opportunity fund is $400 million, up from $350 million.
A Smaller Partnership, A Bigger Checkbook
The remaining active partners are Fred Wilson, Nick Grossman, Rebecca Kaden and Michael Mignano, who joined in April. Longtime partners Brad Burnham, Albert Wenger, Andy Weissman and John Buttrick are moving to reduced or advisory roles, keeping board seats and investment authority but stepping back from day-to-day decisions, according to a second report from Weex. USV has historically written seed-era checks and co-invested alongside Series A specialists rather than leading growth rounds.
“That's a narrower mandate than the generalist seed investing USV built its reputation on in the 2010s, when it backed Twitter, Etsy and Coinbase at early stages.”
Wilson said the larger fund size would let USV "lead rounds requiring checks of about $30 million" -- a meaningful jump from the firm's traditional seed check and one that puts it in more direct competition with multi-stage funds like Lightspeed, a16z and Sequoia, all of which have pushed first checks well past the traditional Series A line as AI-native startups scale revenue faster than prior cohorts.
The new capital is earmarked for four themes: AI applications, data generated through physical intelligence or robotics, consumer and enterprise intelligence, and energy. That's a narrower mandate than the generalist seed investing USV built its reputation on in the 2010s, when it backed Twitter, Etsy and Coinbase at early stages.
However, the bigger numbers don't resolve the staffing math: a four-person active partnership making $30 million-plus commitments has less bandwidth for the high-volume, high-touch seed investing that built USV's brand, and the firm is entering a more crowded field. AI-focused seed and early-stage funds have proliferated through 2026, compressing the pricing advantage a recognizable name like USV once carried on its own.
The test is whether a smaller partner bench can deploy $900 million without diluting the hands-on diligence that distinguished USV's earliest bets. Its next fund reports will show whether the $30 million check size becomes the norm or stays reserved for the firm's highest-conviction deals.